FRANKFURT (dpa-AFX) - The attempt to stabilize Sartorius shares did not last long: After small gains the previous day following the annual report, the shares of the laboratory equipment supplier plummeted on Friday to another low since May 2020. They lost 3.8 percent to 247.80 euros, after having cost almost 278 euros again at times the day before. Since the forecast reduction a week ago, the minus now amounts to 23 percent.

The medium-term targets of Gottingen have also been under scrutiny since the forecast for the current year was lowered, which recently caused particular unease among investors. There will be no news on this until the beginning of 2024. Until then, there is uncertainty, which Borsianer does not like.

Warburg analyst Michael Heider cut his forecasts after the conference call on the weak third quarter and cut his price target to 278 euros. According to Heider, however, management was confident that the fundamental market trends are intact and that a return to double-digit growth rates should be possible in the medium term.

The shares of the Sartorius Stedim Biotech subsidiary, which were also punished, have held up better overall in recent days. After falling 21 percent, they already bottomed out on Monday and have since stabilized. On Friday, however, they again came under greater pressure./ag/ajx/tih